All In MedTech

Device Trial Radar · NCT03430245

VelaShape III & UltraShape Power for Thigh Circumference Reduction

Pilot Study to Evaluate VelaShape III & UltraShape Power Combined Treatment for Thigh Circumference Reduction

Last checked: Nov 20, 2026Latest source record: Jan 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

16

Actual

Start

Feb 19, 2018

Primary completion

May 30, 2019

Study completion Jul 3, 2019

Sponsor

Lead sponsor
Syneron MedicalNot on our public-company list
Sponsor type
Industry
First posted
Feb 12, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Prospective, one-arm, baseline-controlled pilot study for the evaluation of the VelaShape III combined with UltraShape Power treatment for non-invasive circumference reduction to the thighs.

Conditions

  • Circumference Reduction

Interventions

  • VelaShape IIIDevice

    The VelaShape III device combines controlled infrared (IR) light and conducted bipolar radiofrequency (RF) energies with vacuum.

  • UltraShape PowerDevice

    The UltraShape Power device uses focused ultrasound energy for lipolysis (breakdown of fat) via a non-thermal mechanism of action.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Circumference Change in the Thighs at the 12-week Follow-up Compared to Baseline MeasurementsTime frame: At 12 weeks after the third treatment (week 16) for each subject

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Skin Laser & Surgery Specialist of NY/NJ

    Hackensack, New Jersey

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.